cytokines and cytokine therapy, is illustrative of the mission of FOCIS, which seeks to foster interdisciplinary approaches to both understand and treat immune-based diseases.

Charles River and Akron Bio have announced the integration of the latter’s CSS liquid cytokines into the former's Cell ...

Merck seems to have identified cytokines as a fertile ground for exploration, as the Synthekine deal follows its earlier $1.9 billion takeover of Pandion Therapeutics, which is developing a ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated ... dose of FT596 was not reached, and cytokine release syndrome (CRS) was reported ...

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone ...

Charles River Laboratories and Akron Bio have announced the integration of the latter’s closed system solutions (CSS) liquid cytokines into Charles River’s Cell Therapy Flex platform for ...

Home > Pressemitteilung: On the way to curing type 1 diabetes ... MHH team aims to intervene in the autoimmune process and stop the destruction of insulin-producing beta cells in the pancreas ...

Charles River Laboratories International, Inc. (CRL) and Akron Bio announced Thursday the integration of Akron's Closed System ...